| [1] |
Flanagan FL, Dehdashti F, Siegel BA, et al. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography[J]. Am J Roentgenol, 1997, 168:417-424.
|
| [2] |
Stephen J, Skehan MB, Andrea L, et al. Imaging features of primary and recurrent esophageal cancer at FDG PET[J].Radiographics, 2000, 20:713-723.
|
| [3] |
Kata H, Kuwano H, Nakajima M, et al. Comparison between positron assessment of esophageal carcinoma[J]. Cancer,2002, 94:921-928.
|
| [4] |
Yoon CH, Lee KS, Shim YM, et al. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma:CT versus FDG PET for presurgical defeotion prospective study[J]. Radiology, 2003, 227(3):764-770.
|
| [5] |
Flamen P, Leurt A, van Cutsem E, et al. Utility of 18F-FDG positon emission tomagraphy for the staging of patients with potentially oprable esophageal carcinoma[J]. J Clin Oncol,2000, 18:3202-3210.
|
| [6] |
Rankin SC, Taylor H, Cook GJ, et al. Computed tomography and positron emission tomography in the pre-operative staging ofoesophageal carcinoma[J]. Clin Radiol, 1998, 53:659-665.
|
| [7] |
Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging:physiologic and benign variants[J].Radiographics, 1999, 19(1):61-77.
|
| [8] |
Weber WA, Ott k, Becker K, et al. Prediction of response of to preoperative chemotherapy in adenocarcinoma of esophagogastric junction by metabolic imaging[J]. J Clin Oncol,2001, 19:3058-3065.
|
| [9] |
Brucher BL, Weber W, Bauer M, et al. Neoadjuvant the therapy of esophageal squamous cell carcinoma:response evalution by positron emission tomography[J]. Ann Surg,2001,233:300-309.
|
| [10] |
Couper GW, McAteer D, Wallis F, et al. Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer[J]. Br J Surg,1998, 85:1403-1406.
|